Preferred Characteristics of Vaginal Microbicides in Women with Bacterial Vaginosis
Robert L. Cook, Sharon L. Hillier(Magee-Womens Research Institute), Julie S. Downs(Carnegie Mellon University), Pamela J. Murray(Children's Hospital of Pittsburgh), Harold C. Wiesenfeld(Magee-Womens Hospital), Özlem Tanrıöver(Yeditepe University), Jeanne Marrazzo(St. Vincent's Birmingham), Galen E. Switzer(University of Pittsburgh)
Cited by 5
Related Papers
Tenofovir-Based Preexposure Prophylaxis for HIV Infection among African Women
|New England Journal of Medicine|2015|1.3k
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
|New England Journal of Medicine|2021|847
Advancing Health Disparities Research Within the Health Care System: A Conceptual Framework
|American Journal of Public Health|2006|763
Metronidazole to Prevent Preterm Delivery in Pregnant Women with Asymptomatic Bacterial Vaginosis
|New England Journal of Medicine|2000|679